Stifel Nicolaus Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $2.00

Chronological Source Flow
Back

AI Fusion Summary

Stifel Nicolaus cuts Health Catalyst target to $2.00, hold rating; Cantor Fitzgerald lowers to $3.00, neutral; Canaccord Genuity trims to $2.00, buy; Citigroup also reduced target, reflecting market uncertainty for investors.
15/03 08:38 defenseworld.net
3 Πηγές
15/03 09:56 defenseworld.net
15/03 10:46 defenseworld.net
Comments
Loading...
0